|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 90, 454-455, Copyright © 1986 by American College of Chest Physicians
ARTICLES |
EH Busch, DW Snyder and RE Barron 3d
A case of angiographically-documented embolism is presented in a patient using oral contraceptives (OC) with marked mitral valve prolapse (MVP) and an atrial thrombus. OC use has been shown to decrease levels of antithrombin III and increase platelet coagulant activity. This increased coagulability may increase the risk of intra- atrial thrombus formation and subsequent cerebral embolism in patients with MVP. We believe that MVP, especially when redundant valve leaflets are recognized, may be a relative contraindication to OC use.
This article has been cited by other articles:
![]() |
D. Gilon, F. S. Buonanno, M. M. Joffe, M. Leavitt, J. E. Marshall, J. P. Kistler, and R. A. Levine Lack of Evidence of an Association between Mitral-Valve Prolapse and Stroke in Young Patients N. Engl. J. Med., July 1, 1999; 341(1): 8 - 13. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |